Rod Passman
@PassmanRod
Followers
1K
Following
536
Media
2
Statuses
240
Rod Passman is a cardiac electrophysiologist at Northwestern Memorial Hospital and a Professor of Medicine at Northwestern University
Chicago, IL
Joined March 2015
Congratulations to @DJ_Lakkireddy for another educational and inspiring KCHRS this year - and to Dr. Michael Gold for receiving the Pioneer in EP Award. A true pioneer. @PassmanRod @ChrisMalaisrie @NMCardioVasc
1
10
57
Check out our discussion on a very important analysis from NOAH-AFNET 6 and ARTESiA. Many thanks to @PassmanRod and @True_EP for the invitation. @NMCardioVasc @HRSonline
NEW EPISODE OF THE LEAD! [Ep. 73] A Discussion of Time to Benefit and Harm of Direct Oral Anticoagulants in Device-Detected Atrial Fibrillation: A Pooled Analysis of the NOAH-AFNET 6 and ARTESiA Trials 🎙️ Host: @True_EP 🎤 Guests: @PassmanRod and @GrahamPeigh Listen on
0
5
22
ICYMI: #OriginalResearch: Device recognized #AFib was associated with mortality among 21,391 patients with cardiac implantable electronic devices. #AHAJournals @GrahamPeigh @PassmanRod @NMCardioVasc @NorthwesternMed
2
7
18
Rod S. Passman, MD (@PassmanRod), provides #ThoughtLeadership on the benefits of patients using an #AppleWatch to monitor #HeartDiseases and track overall health metrics. Dr. Passman highlights how this will help patients be more involved in their #HealthCare.
1
2
8
Whoa, congrats @GrahamPeigh @PassmanRod @CircAHA Important data supporting relationship between AF burden and clinical outcomes in patients with CIEDs. https://t.co/QjuEj0CFd9
ahajournals.org
BACKGROUND: Current estimates of atrial fibrillation (AF)–associated mortality rely on claims- or clinical-derived diagnoses of AF, limit AF to a binary entity, or are confounded by comorbidities....
1
1
6
#OriginalResearch: Device recognized #AFib was associated with mortality among 21,391 patients with cardiac implantable electronic devices. @GrahamPeigh @PassmanRod @NMCardioVasc @NorthwesternMed
ahajournals.org
BACKGROUND: Current estimates of atrial fibrillation (AF)–associated mortality rely on claims- or clinical-derived diagnoses of AF, limit AF to a binary entity, or are confounded by comorbidities....
0
3
8
Device recognized #AFib was associated with mortality among 21,391 patients with cardiac implantable electronic devices @GrahamPeigh @PassmanRod @NMCardioVasc @NorthwesternMed
ahajournals.org
BACKGROUND: Current estimates of atrial fibrillation (AF)–associated mortality rely on claims- or clinical-derived diagnoses of AF, limit AF to a binary entity, or are confounded by comorbidities....
0
8
19
The #AppleWatch is not a medical device, but it could help some patients manage conditions such as abnormal rhythms of the heart. @PassmanRod, MD, of @NMCardioVasc @NorthwesternMed joined @CBSNews to talk about some of the possible health benefits.
1
2
5
Rod S. Passman, MD (@PassmanRod), joins @CBSnews to discuss why physicians are recommending Apple watches for their patients and provides #ThoughtLeadership on the possible benefits, including monitoring #HeartDisease and post-surgery recovery.
0
3
14
Join #HRX2024 KOL @PassmanRod in Atlanta for this session: "Innovation’s Last Mile: The Journey To Implement Digital Health in 2024." Learn more & register today https://t.co/hybAj3XPaJ
#EPeeps #cardiotwitter
0
3
9
Rhythm Evaluation for Anticoagulation (REACT-AF) Trial Now Open for Enrollment. The @NUCATSInstitute-supported effort led by @PassmanRod is using a scientifically validated smartwatch algorithm to evaluate personalized care unique to each patient — https://t.co/BGhbWdIZWN
0
10
20
Many thanks to #JACCEP for amplifying our recent manuscript: "Impact of Atrial Fibrillation Burden on Health Care Costs and Utilization" https://t.co/N9BKUwOLph Editorial (Dr. Michael Kim): https://t.co/GjauKvgVzV Podcast (Dr. @ratika_parkash):
jacc.org
1
2
13
Introducing Part 1 of a #podcast series on the CAMELOT study, examining ambulatory cardiac monitoring! Explore how this study showcases patient outcomes & healthcare resource utilization among modalities. @PassmanRod @drsuneet @leftbundle @iRhythmTech
https://t.co/bO1YLbzGPJ
0
6
8
That is a wrap for the @MDT_EPAblation Summit. Grateful for an incredible 2.5 days at the Cardiac Ablation Summit, exploring the future of pulsed field technologies with top-notch faculty and Co-Chair @drsuneet. The panel discussions and audience engagement were truly inspiring!
2
8
59
✒️Just accepted in @JACCJournals #JACCEP, we describe the associations between device-recognized #AF / #AF burden, healthcare costs 💵 and healthcare utilization (HCU). 🔗 https://t.co/y14dz93QEK A brief thread of our main findings below ⬇️
1
8
41
In this @JACCJournals #JACCAdvances editorial, @RBPatelMD and I discuss the clinical and subclinical risk factors a/w cryptogenic stroke. Given the relationship between AF and stroke, impt to appropriately adjudicate AF clinically, and in future studies https://t.co/X7nYkW1ZFQ
2
6
27
.@PassmanRod Do we condemn our #AFib patients to lifelong #anticoagulation for episodes >6 hrs or does stroke risk wax & wane based on episodes of AFib? The REACT-AF trial strives to answer this question with pill-in-pocket #OAC & #smartwatch detected #AFib
#WAFib2024
1
20
65
Fantastic @hopkinsheart Grand Rounds on the future of anticoagulation (timing and length) in atrial fibrillation by @PassmanRod from @NorthwesternU. New trial coming!! #atrialfibrillation
1
9
30
Direct-to-consumer wearables have become increasingly popular & available in recent years, massively expanding available diagnostic & management strategies What are some of the promises & concerns of this technology? 🤔 https://t.co/Pfo0mxpX1v
#JACC #AFib
0
20
45
Congratulations @NMCardioVasc Northwestern EP team for an incredible 2023 - delivering outstanding high quality EP procedural care to our patients during 1,782 invasive cases last year.
6
8
80